TickerFacts.

Company research / IRMD

Iradimed Corp (IRMD)

Build a valuation ↗↓ Download CSV

SEC name IRADIMED CORP · CIK 0001325618 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Iradimed Corp reported revenue of $83.81M. Revenue grew 14.4% from the prior annual period.

Key ratios (year ended 2025-12-31)

76.7%
Gross margin
31.2%
Operating margin
26.8%
Net margin
23.8%
Return on year-end equity
14.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-25

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$83.81M$73.24M$65.56M$53.30M$41.81M$31.72M$38.52M$30.44M$23.08M$32.50M
Cost of Revenue$19.49M$16.89M$15.40M$12.02M$9.76M$8.14M$8.82M$7.21M$5.57M$6.15M
Gross Profit$64.32M$56.35M$50.16M$41.28M$32.05M$23.57M$29.70M$23.23M$17.51M$26.34M
R&D Expense$2.98M$2.83M$2.86M$2.28M$1.91M$1.90M$1.43M$1.52M$1.72M$1.35M
Operating Income$26.15M$21.96M$20.04M$15.63M$9.82M-$756.1K$8.65M$6.00M$1.29M$10.92M
Depreciation & Amortization$1.17M$818.0K$765.2K$670.7K$1.41M$1.34M$1.24M$1.11M$1.31M$955.8K
EBITDA$27.31M$22.78M$20.80M$16.30M$11.22M$582.7K$9.89M$7.11M$2.59M$11.88M
Net Income$22.48M$19.23M$17.19M$12.83M$9.33M$1.37M$9.63M$6.30M$499.8K$7.21M
EPS (Diluted)$1.75$1.50$1.35$1.02$0.74$0.11$0.78$0.52$0.04$0.60
Total Assets$108.78M$98.33M$92.16M$85.51M$82.88M$71.07M$66.73M$48.44M$39.01M$37.19M
Total Liabilities$14.16M$11.51M$20.74M$11.84M$10.71M$9.68M$11.20M$6.50M$6.08M$5.31M
Shareholders' Equity$94.62M$86.82M$71.42M$73.67M$72.17M$61.38M$55.52M$41.95M$32.93M$31.89M
Cash & Equivalents$51.16M$52.23M$49.76M$57.96M$62.00M$50.07M$43.48M$28.03M$18.21M$17.71M
Operating Cash Flow$24.95M$25.62M$13.47M$10.04M$11.26M$5.82M$10.23M$7.38M$3.42M$9.41M
Capital Expenditures$7.76M$8.01M$7.44M$823.0K$482.3K$443.0K$368.3K$228.3K$775.6K$780.8K
Free Cash Flow$17.18M$17.62M$6.02M$9.22M$10.78M$5.37M$9.86M$7.15M$2.64M$8.63M
Share Repurchasesn/an/an/an/an/an/an/an/a$1.82M$9.97M
Dividends Paid$15.04M$13.68M$13.22M$12.56Mn/an/an/an/an/an/a
Shares Outstanding12.78M12.71M12.66M12.59M12.54M12.31M11.77M10.99M10.60M10.72M
Weighted Average Diluted Shares12.85M12.78M12.72M12.64M12.59M12.44M12.28M12.11M11.72M11.99M
EPS (Basic)$1.77$1.52$1.36$1.02$0.76$0.11$0.85$0.59$0.05$0.67

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView